Harvard Apparatus Regenerative Technology Common Stock Net 2013-2025 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Harvard Apparatus Regenerative Technology common stock net from 2013 to 2025. Common stock net can be defined as the value of common equity ownership.

Harvard Apparatus Regenerative Technology Common Stock Net 2013-2025 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Harvard Apparatus Regenerative Technology common stock net from 2013 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$136B
CVS Health (CVS)	$78.4B
Elevance Health (ELV)	$62.6B
Cencora (COR)	$56.8B
DiDi Global (DIDIY)	$26.9B
Labcorp Holdings (LH)	$20.4B
Natera (NTRA)	$19B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$14B
CochLear (CHEOY)	$13.1B
Solventum (SOLV)	$12.7B
ICON (ICLR)	$11.6B
Revvity (RVTY)	$11B
Viatris (VTRS)	$10.4B
Avantor (AVTR)	$9.1B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$8.9B
HealthEquity (HQY)	$8.4B
Caris Life Sciences,�Inc (CAI)	$7.7B
Charles River Laboratories (CRL)	$7.6B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.1B
Surgery Partners (SGRY)	$2.9B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
Alignment Healthcare (ALHC)	$2.5B
GeneDx Holdings (WGS)	$2.2B
Progyny (PGNY)	$1.9B